Stabilization of human urine doping control samples: A current opinion

Analytical and Bioanalytical Chemistry

Volumn 401, Issue 2, 2011, Pages 553-561

  Tsivou, Maria ^a,c   Georgakopoulos, Dimitrios G ^b   Dimopoulou, Helen A ^a   Koupparis, Michael A ^c   Atta Politou, Julia ^c   Georgakopoulos, Costas G ^a  

^a OAKA   (Greece)

^b AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Doping control analysis; Endogenous steroids; Human chorionic gonadotropin; Microorganisms; Recombinant erythropoietin; Urine stabilization

Indexed keywords

DOPING-CONTROL ANALYSIS; ENDOGENOUS STEROIDS; HUMAN CHORIONIC GONADOTROPINS; RECOMBINANT ERYTHROPOIETIN; URINE STABILIZATION;

DEGRADATION; HORMONES; LIPIDS; PEPTIDES; STABILIZATION;

BODY FLUIDS;

CHORIONIC GONADOTROPIN; ERYTHROPOIETIN; STEROID;

ANALYSIS; ARTICLE; DOPING; HUMAN; METHODOLOGY; SENSITIVITY AND SPECIFICITY; STANDARD; SUBSTANCE ABUSE; URINE;

ANALYTIC SAMPLE PREPARATION METHODS; CHORIONIC GONADOTROPIN; DOPING IN SPORTS; ERYTHROPOIETIN; HUMANS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; STEROIDS; SUBSTANCE ABUSE DETECTION;

EID: 79960564509     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-4887-5     Document Type: Article

References (43)

1. BS Rushall M Jones 2006 The anti-drugs-in-sport movement: causes for concern International Journal of Sports Science and Coaching 1 1 1 18 10.1260/174795406776338445
2. JG Kuenen WN Konings 2010 The importance of cooling of urine samples for doping analysis Accredit Qual Assur 15 133 136 10.1007/s00769-009-0601-0 1:CAS:528:DC%2BC3cXhsFansLg%3D
3. Geyer H, Schänzer W, Mareck-Engelke U, Donike M (1995) Factors influencing the steroid profile. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (3). Sportverlag Strau, Köln, pp 95-113
4. Hemmersbach P, Birkeland KI, Norli HR, Ringertz SH (1997) Urine storage conditions and steroid profile analysis. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (4). Sportverlag Strau, Köln, pp 99-106
5. Ayotte C, Charlebois A, Lapointe S, Barriault D, Sylvestre M (1997) Validity of urine samples: microbial degradation. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Recent advances in doping analysis (4). Sportverlag Strau, Köln, pp 127-137
6. Ayotte C, Charlebois A, Lapointe S, Sylvestre M, Barriault D (1997) Microbial degradation of urine samples collected in Athletic Drug testing programmes. Report submitted to the International Athletic Foundation, IAF Project, pp 93-96
7. R de la Torre X de la Torre C Alia J Segura T Baro JM Torres-Rodriguez 2001 Changes in androgenic steroid profile due to urine contamination by microorganisms: a prospective study Anal Biochem 289 116 122 10.1006/abio.2000.4918 (Pubitemid 32173658)
8. AT Kicman JK Fallon DA Cowan C Walker S Easmon D Mackintosh 2002 Candida albicans in urine can produce testosterone: impact on the testosterone/ epitestosterone sports drug test Clin Chem 48 1799 1801 1:CAS:528: DC%2BD38XnsV2gs7o%3D
9. Kwiatkowska D, Pokrywka A, Jaźwiec R, Turek-Lepa E, Starościak B, Lewandowska-Pachecka S, Pachecka J, Grucza R (2005) The research of microbiological stability in anti-doping samples. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds) Recent Advances in Doping Analysis (13). Sportverlag Strau, Köln, pp 453-456
10. M Tsivou D Livadara DG Georgakopoulos M Koupparis J Atta-Politou CG Georgakopoulos 2009 Stabilization of human urine doping control samples Anal Biochem 388 2 179 191 10.1016/j.ab.2009.02.016 1:CAS:528:DC%2BD1MXkvVWgtbk%3D
11. C Ayotte D Goudreault A Charlebois 1996 Testing for natural and synthetic anabolic agents in human urine J Chromatogr B 687 3 25 10.1016/S0378-4347(96) 00032-1 1:STN:280:DyaK2s7lsFagtw%3D%3D (Pubitemid 27008303)
12. DH van de Kerkhof D de Boer JHH Thijssen RAA Maes 2000 Evaluation of Testosterone/Epitestosterone ratio influential factors as determined in doping analysis J Anal Toxicol 24 102 115 (Pubitemid 30134313)
13. U Mareck H Geyer G Opfermann M Thevis W Schänzer 2008 Factors influencing the steroid profile in doping control analysis J Mass Spectrom 43 877 891 10.1002/jms.1457 1:CAS:528:DC%2BD1cXptVehurs%3D (Pubitemid 352029656)
14. WADA (2004) Technical document-TD2004EAAS ver.1.0. Reporting and evaluation guidance for testosterone, epitestosterone, T/E ratio and other endogenous steroids. Available at: http://www.wada-ama.org/rtecontent/document/ end-steroids-aug-04.pdf. Accessed 6 December 2010
15. S Ojanperä A Leinonen J Apajalahti M Lauraeus S Alaja T Moisander A Kettunen 2010 Characterization of microbial contaminants in urine. Drug test Analysis 2 576 581
16. M Thevis J Maurer M Kohler W Schänzer 2007 Proteases in doping control analysis Int J Sports Med 28 545 549 10.1055/s-2007-965159 1:CAS:528:DC%2BD2sXpslOrt7Y%3D (Pubitemid 47080133)
17. M Kohler A Thomas H Geyer L Horta W Schänzer M Thevis 2009 Detection of the protease Bacillolysin in doping-control urine samples Drug Test Analysis 1 143 145 10.1002/dta.29 1:CAS:528:DC%2BD1MXhtVyntr%2FN
18. A Thomas M Kohler K Walpurgis W Schänzer M Thevis 2009 Proteolysis and autolysis of proteases and the detection of degradation products in doping control Drug Test Analysis 1 81 86 10.1002/dta.20 1:CAS:528:DC%2BD1MXkvFGmtbc%3D
19. Horta L (2010) Collaboration between law enforcement and NADOs-the tampering with proteases affair. 9th Annual USADA Symposium on Anti-Doping Science Lansdowne. Virginia, USA
20. WADA (2010) The World Anti-Doping Code, The 2010 the prohibited list, International standard. Available at: http://www.wada-ama.org/Documents/World- Anti-Doping-Program/WADP-Prohibited-list/WADA-Prohibited-List-2010-EN.pdf. Accessed 6 December 2010
21. Lasne F, Martin L, de Ceaurriz J (2005) Active urine and detection of recombinant erythropoietin. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds) Recent advances in doping analysis (13). Sportverlag Strau, Köln, pp 297-304
22. S Lamon N Robinson P-E Sottas H Henry M Kamber P Mangin M Saugy 2007 Possible origin of undetectable EPO in urine samples Clin Chim Acta 385 61 66 10.1016/j.cca.2007.06.018 1:CAS:528:DC%2BD2sXhtVCgsLrE (Pubitemid 47374667)
23. C Saudan JM Entenza N Baume P Mangin M Saugy 2006 Short-term stability of testosterone and epitestosterone conjugates in urine samples: quantification by liquid chromatography-linear ion trap mass spectrometry J Chromatogr B 844 168 174 10.1016/j.jchromb.2006.07.010 1:CAS:528:DC%2BD28Xht1SjsrfF (Pubitemid 46048611)
24. Belalcazar V, Pascual JA, Abanades S, Farré M, de la Torre R (2005) Stability of EPO in urine stabilized by sodium azide. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds) Recent advances in doping analysis (13). Sportverlag Strau, Köln, pp 427-431
25. Dehnes Y, Borgen M, Hemmersbach P (2007) Enzymatic digestion of EPO. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds) Recent advances in doping analysis (15). Sportverlag Strau, Köln, pp 405-408
26. U-H Stenman K Hotakainen H Alfthan 2008 Gonadotropins in doping: pharmacological basis and detection of illicit use Br J Pharmacol 154 569 583 10.1038/bjp.2008.102 1:CAS:528:DC%2BD1cXmt1KqtL8%3D (Pubitemid 351744939)
27. JW Honour 1996 Testing for drug abuse Lancet 348 41 43 10.1016/S0140-6736(96)05336-6 1:STN:280:DyaK28zht1ahsA%3D%3D (Pubitemid 26237246)
28. WADA (2010) The World Anti-Doping Program, Guidelines for urine sample collection ver. 5.1. Available at: http://www.wada-ama.org/Documents/Resources/ Guidelines/WADA-Guidelines-Urine-Sample-Collection-v5.1.pdf. Accessed 6 December 2010
29. WADA (2010) The World Anti-Doping Program, Guidelines for blood sample collection ver. 2.2. Available at: http://www.wada-ama.org/Documents/Resources/ Guidelines/WADA-Guidelines-Blood-Sample-Collection-v2.2.pdf. Accessed 6 December 2010
30. MJ Evans JH Livesey MJ Ellis TG Yandle 2001 Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones Clin Biochem 34 2 107 112 10.1016/S0009-9120(01)00196-5 1:CAS:528:DC%2BD3MXjs1Ogtbs%3D (Pubitemid 32322701)
31. MJ Ellis JH Livesey MJ Evans 2003 Hormone stability in human whole blood Clin Biochem 36 2 109 112 10.1016/S0009-9120(02)00440-X 1:CAS:528: DC%2BD3sXjtlelu7w%3D (Pubitemid 36287490)
32. AG Renehan J Jones ST O'Dwyer SM Shalet 2003 Determination of IGF-I, IGF-II, IGFBP-2, and IGFBP-3 levels in serum and plasma: comparisons using the Bland-Altman method Growth Horm IGF Res 13 6 341 346 10.1016/S1096-6374(03) 00112-6 1:CAS:528:DC%2BD3sXovF2ksbg%3D (Pubitemid 37493325)
33. RI Holt I Erotokritou-Mulligan SA Ridley CM McHugh EE Bassett DA Cowan C Bartlett PH Sönksen 2009 A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide Growth Horm IGF Res 19 1 43 50 10.1016/j.ghir.2008.06.001 1:CAS:528: DC%2BD1MXhtlOlsLo%3D
34. Tsivou M, Livadara D, Georgakopoulos DG, Koupparis M, Atta-Politou J, Georgakopoulos CG (2008) Preservation of urine doping control samples: preliminary results. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds) Recent advances in doping analysis (16). Sportverlag Strau, Köln, pp 41-50
35. M Tsivou D Livadara DG Georgakopoulos M Koupparis J Atta-Politou CG Georgakopoulos 2009 Stabilization of human urine doping control samples: II. Microbial degradation of steroids Anal Biochem 388 1 146 154 10.1016/j.ab.2009.02.013 1:CAS:528:DC%2BD1MXktFamsbg%3D
36. M Tsivou HA Dimopoulou I-P Leontiou DG Georgakopoulos M Koupparis J Atta-Politou CG Georgakopoulos 2010 Stabilization of human urine doping control samples: III. Recombinant human erythropoietin Clin Chim Acta 411 5-6 448 45237 10.1016/j.cca.2009.11.029 1:CAS:528:DC%2BC3cXhtlCmsbk%3D
37. M. Tsivou HA Dimopoulou DG Georgakopoulos MA Koupparis J Atta-Politou CG Georgakopoulos 2010 Stabilization of human urine doping control samples: IV. Human Chorionic Gonadotropin Anal Bioanal Chem 398 3 1313 1318 10.1007/s00216-010-4033-9 1:CAS:528:DC%2BC3cXpt1yis7g%3D
38. PA Mackowiak 1982 The normal microbial flora N Engl J Med 307 2 83 93 10.1056/NEJM198207083070203 1:STN:280:DyaL383hvFymsg%3D%3D
39. F Guarner JR Malagelada 2003 Gut flora in health and disease Lancet 361 512 519 10.1016/S0140-6736(03)12489-0 (Pubitemid 36173720)
40. ML Wilson L Gaido 2004 Laboratory diagnosis of urinary tract infections in adult patients Clin Infect Dis 38 1150 1158 10.1086/383029 (Pubitemid 38951264)
41. Schwab CJ, Straus DC (2004) The roles of Penicillium and Aspergillus in sick building syndrome. In: Straus DC (ed) Advances in Applied Microbiology, vol 55. Elsevier Academic Press, San Diego, pp 215-238 (Pubitemid 39179935)
42. WADA (2009) Technical Document - TD2009EPO ver. 2.0. Harmonization of the method for the identification of recombinant erythropoietins (i.e. epoetins) and analogues (e.g. darbepoetin and methoxypolyethylene glycol-epoetin beta). Available at: http://www.wada-ama.org/Documents/World-Anti-Doping-Program/WADP- IS-Laboratories/WADA-TD2009EPO-EN.pdf. Accessed 6 December 2010
43. A Bristow P Berger JM Bidart S Birken R Norman UH Stenman C Sturgeon 2005 Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin Clin Chem 51 177 182 10.1373/clinchem.2004.038679 1:CAS:528:DC%2BD2MXlt1ymtw%3D%3D (Pubitemid 40024028)